ロード中...
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review
BACKGROUND: Open-label, randomized controlled trials (RCTs) are subject to observer bias. If patient management is conducted without blinding, a difference between groups may be explained by other factors than study treatment. One factor may come from taking concomitant treatments with an efficacy o...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3765855/ https://ncbi.nlm.nih.gov/pubmed/24229055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2288-13-107 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|